Navigation Links
Orthopedic Surgeon, Dr. Mark McFarland, Completes Milestone Case With NanoFUSE® Biologics Technology
Date:4/17/2019

NanoFUSE Biologics announced today that Dr. Mark McFarland completed his 50th case using NanoFUSE Biologics. The operation took place on Thursday, March 28, 2019 at Mary Immaculate Hospital in Newport News, Virginia. Dr. McFarland performed a posterior lumbar interbody fusion and removal of hardware on a 71-year-old male patient.

NanoFUSE Biologics is the only bioactive glass that is FDA-cleared to be combined with demineralized bone matrix (DBM). Bioactive glass has been clinically proven in orthopedics for over 30 years. NanoFUSE Biologics has now created a revolutionary and patented biologic using bioactive glass.

“The patented NanoFUSE manufacturing process produces an advanced bioactive glass/DBM combination with high efficacy that has been demonstrated in animal studies,” states NanoFUSE President, Jake Lubinski. “We’re excited about the growing surgeon adoption of NanoFUSE across all orthopedic practices, not just spine. To date, it has been used by over 300 surgeons and implanted in over 1200 patients.”

Dr. McFarland noted, “I’ve been excited to use NanoFUSE Biologics for its osteoinductive and osteoconductive properties which aids in the healing process. I’ve used NanoFUSE in my cervical and lumbar cases along with orthopedic applications outside of spine, and I’ve been pleased with the results."

Prior to undergoing surgery with Dr. McFarland, the patient had a previous fusion at L3-5 and experienced chronic pain since his initial surgery. Over time, the pain in his right and left gluteus made it increasingly difficult to stand or walk. After failing conservative treatments, including pain management and epidural injections, he opted for surgery. Lumbar X-rays revealed degenerative disc disease at L2-3 and L5-S1, and his MRI showed moderate central and lateral recess stenosis at L2-3 and 5-1. The patient demonstrated weakness and radiculopathy in both lower extremities. The patient is in good health after his procedure.

About NanoFUSE
NanoFUSE is the synergistic blend of osteoinductive DBM combined with the osteostimulative properties of bioactive glass. NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in all orthopedic surgery. NanoFUSE Biologics is a KICVentures portfolio company.

Read the full story at https://www.prweb.com/releases/orthopedic_surgeon_dr_mark_mcfarland_completes_milestone_case_with_nanofuse_biologics_technology/prweb16247909.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Ethiopian-Born Neurosurgeon Dr. Fassil Mesfin and Orthopedic Surgeon Dr. Addisu Mesfin Thank KICVentures for Sponsoring Their Successful Mission Trip to Ethiopia
2. Elevate Your Comfort: Everlasting Comfort® Delivers Versatile Orthopedic Seat Cushion on Amazon
3. University Orthopedics and The Center for Orthopaedics Announce Partnership
4. St. Joseph’s Medical Center Partners with Dynafios to Launch Comprehensive Orthopedic and Spine Program
5. Dr. Brian Gengler, Spine Surgeon, Joins Precision Orthopedics & Sports Medicine
6. OrthoAtlanta is Official Orthopedic and Sports Medicine Provider to Atlanta Football Host Committee for 2018 College Football Playoff National Championship
7. Orthopedic Bone Cement - Medical Devices Pipeline Assessment, 2017
8. Research and Markets - Global Orthopedic Surgical Robots Market to Grow at a CAGR of 46%, 2017-2021 with OMNI, Smith & Nephew, Stryker & THINK Surgical Leading the Way
9. Orthopedic Navigation Systems Market to Reach $303.7 Million by 2025 - Increasing Geriatric Population Prone to Orthopedic Diseases - Research and Markets
10. Medeon Biodesign Announces Investing in Panther Orthopedics for Orthopedic Extremity Applications
11. Medeon Biodesign Announces Investing in Panther Orthorpedic for Orthopedic Extremity Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2019)... (PRWEB) , ... April 18, 2019 , ... CBD ... CBD sales for 4/20 weekend 2019 . The list contains the best sales from ... weekend, many CBD companies will offer deep discounts on popular items. And CBD Hacker ...
(Date:4/18/2019)... ... 18, 2019 , ... ChronWell, a technology-enabled injury ... to participate in the inaugural “RIMS Tech, the Insurtech Competition” at RIMS ... 28th through May 1st. , The competition, which aims to award innovative ...
(Date:4/18/2019)... ... 18, 2019 , ... Mesmerize , a prominent out-of-home ... strategic partnership with Pharmacy Health Network (PHN), the only out-of-home digital ... representatives for PHN. , Together, the two companies will continue to educate and ...
Breaking Medicine Technology:
(Date:4/18/2019)... ... April 18, 2019 , ... She went from learning ... of eyeglasses, said her mother, Cheryl Reilly. Those “goofy tests,” performed by Deborah ... Reilly, then 12 years old, had such narrow range of visual awareness, she could ...
(Date:4/17/2019)... ... April 17, 2019 , ... With Fentanyl overdose deaths continuing to claim lives ... death toll by looking for an alternative to naloxone. Researchers are presenting their ... week. , Naloxone (often known by the name brand Narcan) has been utilized increasingly ...
(Date:4/17/2019)... ... April 17, 2019 , ... The IBS Patient ... this April to designate April 19th as World IBS Day to raise awareness ... healthcare professionals in their pursuit to find treatments. Irritable Bowel Syndrome is a ...
(Date:4/17/2019)... , ... April 17, 2019 , ... ... on advances in revolutionary diagnostic technologies. This episode is scheduled to air 3Q ... this segment, Innovations will focus on Credo Biomedical Pte. Ltd. (Credo Biomedical), a ...
(Date:4/17/2019)... SAN MATEO, Calif. (PRWEB) , ... April 17, 2019 , ... ... a competitive edge thanks to a 2019 Thomas R. Brown Athletics Grant ... purchase new equipment, improve player safety, and provide uniforms. , The grant is ...
Breaking Medicine News(10 mins):